摘要
细胞穿透肽 (CPPs) 先前已被证实为可通过细胞膜和其他生物膜输送多种物质的强大的运输载体工具。并且因其是相对的细胞-、受体-、能量-独立,CPPs在促进药物进入细胞方面有独特的优势。本文简要综述了CPPs的发现、机制和归类,尤其集中于CPPs的具体限制和其用于生物活性分子、成像药物和载体的肿瘤靶向输送的潜在应用。
关键词: 细胞穿透肽,肿瘤,靶向。
图形摘要
Current Cancer Drug Targets
Title:Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging
Volume: 15 Issue: 4
Author(s): Weiqin Wang, Sarra Abbad, Zhenhai Zhang, Shu Wang, Jianping Zhou and Huixia Lv
Affiliation:
关键词: 细胞穿透肽,肿瘤,靶向。
摘要: Cell-penetrating peptides (CPPs) have been previously shown to be powerful transport vector tools for the delivery of a large variety of cargoes through the cell membrane, as well as other physiological membranes. And since they’re relatively cell-, receptor- and energy-independent, CPPs have unique advantages in facilitating drugs entry into cells. This paper briefly reviews the discovery, mechanism and classification of CPPs, and especially focuses on the specific limitations of CPPs and their potential applications for tumor-targeted delivery of biologically active molecules, imaging agents and carriers.
Export Options
About this article
Cite this article as:
Weiqin Wang, Sarra Abbad, Zhenhai Zhang, Shu Wang, Jianping Zhou and Huixia Lv , Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging, Current Cancer Drug Targets 2015; 15 (4) . https://dx.doi.org/10.2174/1568009615666150211104524
DOI https://dx.doi.org/10.2174/1568009615666150211104524 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tumour Gene Therapy Monitoring Using Magnetic Resonance Imaging and Spectroscopy
Current Gene Therapy Emerging Roles of microRNAs in Neural Stem Cells
Current Stem Cell Research & Therapy Research Strategies for Pain in Lumbar Radiculopathy Focusing on Acid-Sensing Ion Channels and Their Toxins
Current Topics in Medicinal Chemistry Recent Advances in the Development of Selective CB2 Agonists as Promising Anti-Inflammatory Agents
Current Medicinal Chemistry Anti-inflammatory Property of AMP-activated Protein Kinase
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Natural Products and Cancer Stem Cells
Current Pharmaceutical Design Neuroblastoma and Stem Cell Therapy: An Updated Review
CNS & Neurological Disorders - Drug Targets Connexins as Precocious Markers and Molecular Targets for Chemical and Pharmacological Agents in Carcinogenesis
Current Medicinal Chemistry Butyrate and Colorectal Cancer: The Role of Butyrate Transport
Current Drug Metabolism KCa3.1 Channels and Glioblastoma: In Vitro Studies
Current Neuropharmacology Risk Assessment of the Use of Autonomous Parvovirus-Based Vectors
Current Gene Therapy The Use of Therapeutic Peptides to Target and to Kill Cancer Cells
Current Medicinal Chemistry Anticancer Natural Products with Collateral Sensitivity: A Review
Mini-Reviews in Medicinal Chemistry Regional Differences in Adaptation of CNS Mu Opioid Receptors to Chronic Opioid Agonist Administration
Current Neuropharmacology MicroRNAs in Cancer Stem Cells: New Regulators of Stemness
Current Pharmaceutical Design Matrix Metalloproteinase Inhibitors as Prospective Agents for the Prevention and Treatment of Cardiovascular and Neoplastic Diseases
Current Topics in Medicinal Chemistry Clinical Applications and Biosafety of Human Adult Mesenchymal Stem Cells
Current Pharmaceutical Design Monofunctional Platinum (PtII) Compounds – Shifting the Paradigm in Designing New Pt-based Anticancer Agents
Current Medicinal Chemistry Evaluation of Skin Permeability of Resveratrol Loaded Liposomes and Nanostructured Lipid Carriers using a Skin Mimic Artificial Membrane (skin-PAMPA)
Drug Delivery Letters Modern drug delivery systems for targeting the posterior segment of the eye
Current Pharmaceutical Design